KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Liabilities (2017 - 2026)

Twist Bioscience has reported Total Liabilities over the past 10 years, most recently at $221.1 million for Q1 2026.

  • Quarterly Total Liabilities rose 42.19% to $221.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $221.1 million through Mar 2026, up 42.19% year-over-year, with the annual reading at $168.9 million for FY2025, 19.25% up from the prior year.
  • Total Liabilities was $221.1 million for Q1 2026 at Twist Bioscience, up from $182.0 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $221.1 million in Q1 2026 and troughed at $141.6 million in Q3 2024.
  • The 5-year median for Total Liabilities is $155.5 million (2025), against an average of $160.5 million.
  • Year-over-year, Total Liabilities surged 2627.42% in 2022 and then fell 12.75% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $163.6 million in 2022, then fell by 12.75% to $142.8 million in 2023, then grew by 6.91% to $152.6 million in 2024, then increased by 19.23% to $182.0 million in 2025, then rose by 21.5% to $221.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Total Liabilities are $221.1 million (Q1 2026), $182.0 million (Q4 2025), and $168.9 million (Q3 2025).